The Straits Times Index fell 0.2% to 3,295.25 as of 9:16 a.m., the steepest drop since Oct 27. Almost twice as many stocks declined as advanced in the benchmark equity index of 30 companies.

Shares on the measure trade at an average 16 times estimated earnings, compared with about 17.4 times at the beginning of the year, according to data compiled by Bloomberg.

The following shares were among the most active in the market. Stock symbols are in parentheses after the company name.

CapitaLand (CAPL SP), Southeast Asia’s biggest developer, lost 1% to $3.90. The company said it will pay interest on convertible bonds due 2016 on Nov 15.

Keppel Land (KPLD SP), the real-estate unit of Keppel Corp., sank 3.8% to $4.86. The company said it will issue $500 million of unsecured convertible bonds. The convertible bonds will have a term of five years and will be convertible into new Keppel Land ordinary shares, it said.

Sembcorp Industries (SCI SP), the owner of the world’s second-biggest oil-rig maker, rose 0.8% to $4.87. The company said its third-quarter net income rose 65% to $244.1 million.

Wilmar International (WIL SP), the world’s biggest palm-oil trader, climbed 2.1% to $6.87. The company said it increased the size of its syndicated term loan facility to US$1.3 billion ($1.7 billion) from US$1.1 billion to accommodate excess demand. The loan will be used to fund the acquisition of Sucrogen, Australia’s biggest sugar refiner.

Biosensors International Group today announced several changes to the composition of its board of directors.

Following Hony Capital’s previously announced acquisition of a significant equity stake in the company, John H. Zhao, Chief Executive Officer of Hony Capital, and Bing Yuan, Managing Director of Hony Capital, will join the Biosensors board as non‐executive directors.

Meanwhile, former CEO R. Michael Kleine and Dr Lincoln Chee Wang Jin have announced their resignations from the board. In addition to the changes at board level, the company also announced that Jeffrey B. Jump and Dr Jack Wang would serve as Co‐Chief Executive Officers of the company, with Dr Wang focusing on the company’s operations and China strategy while Jump continuing to lead the company’s strategy outside of China. Dr Wang will also join the board as an executive director.

Currently the company’s Chief Operating Officer, Dr Wang has been with Biosensors since 2001, serving in various roles throughout the organisation, as well as serving as President and Chief Executive Officer of JW Medical Systems, the company’s China‐based drug‐eluting stent joint venture.

Prior to launching Hony Capital in 2003, Zhao held numerous CEO and chairman roles at companies such as eGarden Ventures, Infolio Inc., and Vadem. Zhao also serves as Vice President of Hony’s sponsor firm, Legend Holdings, the parent of Lenovo. Yuan joined Hony in 2009 after spending several years as a Managing Director with Morgan Stanley, most recently responsible for the investment bank’s direct investing activities in China, and brings extensive corporate finance and merger and acquisition experience to the company.

“Our organisation continues to evolve. We recognise Mike and Lincoln’s contributions to our board, and wish them well in their future activities. The resources and experience of our new board members, combined with Jack’s increased involvement in the company, will help strengthen our long‐term commitment to the China market. I look forward to supporting Jack and Jeff as they continue the successful collaboration they started many years ago,” says Yoh‐Chie Lu, Biosensors’ Executive Chairman.